PMC:7212965 / 58975-60140 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T136","span":{"begin":210,"end":216},"obj":"Body_part"},{"id":"T137","span":{"begin":337,"end":342},"obj":"Body_part"}],"attributes":[{"id":"A136","pred":"fma_id","subj":"T136","obj":"http://purl.org/sig/ont/fma/fma228738"},{"id":"A137","pred":"fma_id","subj":"T137","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T104","span":{"begin":210,"end":216},"obj":"Body_part"},{"id":"T105","span":{"begin":337,"end":342},"obj":"Body_part"}],"attributes":[{"id":"A104","pred":"uberon_id","subj":"T104","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"},{"id":"A105","pred":"uberon_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T294","span":{"begin":191,"end":199},"obj":"Disease"},{"id":"T295","span":{"begin":361,"end":372},"obj":"Disease"},{"id":"T296","span":{"begin":361,"end":370},"obj":"Disease"},{"id":"T297","span":{"begin":478,"end":486},"obj":"Disease"}],"attributes":[{"id":"A294","pred":"mondo_id","subj":"T294","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A295","pred":"mondo_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A296","pred":"mondo_id","subj":"T296","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A297","pred":"mondo_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T413","span":{"begin":337,"end":342},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T414","span":{"begin":337,"end":342},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T415","span":{"begin":371,"end":372},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T416","span":{"begin":868,"end":870},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T417","span":{"begin":887,"end":889},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T418","span":{"begin":940,"end":942},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T419","span":{"begin":1030,"end":1032},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T76566","span":{"begin":381,"end":388},"obj":"Chemical"},{"id":"T30260","span":{"begin":404,"end":406},"obj":"Chemical"},{"id":"T87741","span":{"begin":801,"end":804},"obj":"Chemical"}],"attributes":[{"id":"A6319","pred":"chebi_id","subj":"T76566","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A59916","pred":"chebi_id","subj":"T30260","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"},{"id":"A36308","pred":"chebi_id","subj":"T87741","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T263","span":{"begin":361,"end":370},"obj":"Phenotype"},{"id":"T264","span":{"begin":478,"end":486},"obj":"Phenotype"},{"id":"T265","span":{"begin":725,"end":729},"obj":"Phenotype"}],"attributes":[{"id":"A263","pred":"hp_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A264","pred":"hp_id","subj":"T264","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A265","pred":"hp_id","subj":"T265","obj":"http://purl.obolibrary.org/obo/HP_0012531"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T415","span":{"begin":0,"end":42},"obj":"Sentence"},{"id":"T416","span":{"begin":43,"end":79},"obj":"Sentence"},{"id":"T417","span":{"begin":80,"end":107},"obj":"Sentence"},{"id":"T418","span":{"begin":108,"end":146},"obj":"Sentence"},{"id":"T419","span":{"begin":147,"end":292},"obj":"Sentence"},{"id":"T420","span":{"begin":293,"end":321},"obj":"Sentence"},{"id":"T421","span":{"begin":322,"end":357},"obj":"Sentence"},{"id":"T422","span":{"begin":358,"end":477},"obj":"Sentence"},{"id":"T423","span":{"begin":478,"end":487},"obj":"Sentence"},{"id":"T424","span":{"begin":488,"end":566},"obj":"Sentence"},{"id":"T425","span":{"begin":567,"end":645},"obj":"Sentence"},{"id":"T426","span":{"begin":646,"end":730},"obj":"Sentence"},{"id":"T427","span":{"begin":731,"end":809},"obj":"Sentence"},{"id":"T428","span":{"begin":810,"end":875},"obj":"Sentence"},{"id":"T429","span":{"begin":876,"end":943},"obj":"Sentence"},{"id":"T430","span":{"begin":944,"end":1009},"obj":"Sentence"},{"id":"T431","span":{"begin":1010,"end":1099},"obj":"Sentence"},{"id":"T432","span":{"begin":1100,"end":1165},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2219","span":{"begin":404,"end":406},"obj":"Gene"},{"id":"2233","span":{"begin":200,"end":208},"obj":"Species"},{"id":"2296","span":{"begin":1069,"end":1079},"obj":"Chemical"},{"id":"2332","span":{"begin":114,"end":119},"obj":"Disease"},{"id":"2333","span":{"begin":176,"end":190},"obj":"Disease"},{"id":"2334","span":{"begin":191,"end":199},"obj":"Disease"},{"id":"2335","span":{"begin":361,"end":372},"obj":"Disease"},{"id":"2336","span":{"begin":462,"end":476},"obj":"Disease"},{"id":"2337","span":{"begin":478,"end":486},"obj":"Disease"},{"id":"2338","span":{"begin":705,"end":729},"obj":"Disease"}],"attributes":[{"id":"A2219","pred":"tao:has_database_id","subj":"2219","obj":"Gene:2770"},{"id":"A2233","pred":"tao:has_database_id","subj":"2233","obj":"Tax:9606"},{"id":"A2332","pred":"tao:has_database_id","subj":"2332","obj":"MESH:D003643"},{"id":"A2333","pred":"tao:has_database_id","subj":"2333","obj":"MESH:D016638"},{"id":"A2334","pred":"tao:has_database_id","subj":"2334","obj":"MESH:C000657245"},{"id":"A2335","pred":"tao:has_database_id","subj":"2335","obj":"MESH:D006509"},{"id":"A2336","pred":"tao:has_database_id","subj":"2336","obj":"MESH:D016638"},{"id":"A2337","pred":"tao:has_database_id","subj":"2337","obj":"MESH:D003967"},{"id":"A2338","pred":"tao:has_database_id","subj":"2338","obj":"MESH:D010146"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Chen, 202072Tongji Hospital (Wuhan)Dates: 01/13/2020-02/12/2020Last follow-up: 02/28/2020 n = 274Survival: 52.2% death, 47.8% recoveredInclusion: Moderate severity, severe or critically ill COVID-19 patients (throat swab or bronchoalveolar lavage RT-PCR) who were deceased or discharged.Age: M 62.0 y (IQR, 44–70 y) sex: 37.6% femaleGI/liver comorbidities: 4% hepatitis B surface antigen positivity, 1% GI diseasesDisease severity: moderate severity, severe or critically ill. Diarrhea: 28.1% (n = 77)Present on admission27/113 deceased and 50/161 dischargedNausea: 8.8% (n = 24)Present on admission8/113 deceased and 16/161 dischargedVomiting: 5.8% (n = 16)Present on admission6/113 deceased and 10/161 dischargedAbdominal pain: 6.9% (n = 19)Present on admission6/113 deceased and 13/161 discharged AST \u003e40: 30.7% (84)59/113 deceased and 25/161 dischargedM 30 (IQR, 22–46). Deceased M 45 (IQR, 31–67) and discharged M 25 (IQR, 20–33)ALT \u003e41: 21.9% (60)30/113 deceased and 30/161 dischargedM 23 (IQR, 15–38). Deceased M 28 (IQR, 18–47) and discharged M 20 (IQR, 15–32)BilirubinM 0.6 (IQR, 0.4–0.8). Deceased M 0.7 (IQR, 0.6–1.0) and discharged M 0.5 (IQR, 0.3–0.7)"}